Cipla Q1 FY26 Results: With Rs 1,298 crore Q1 profit, Mumbai-based drug maker beats Street estimates; margin steady
Cipla Q1 FY26 Results: Mumbai-headquartered pharmaceutical firm Cipla on Friday reported a 10.2 per cent year-on-year rise in consolidated net profit to Rs 1,298 crore for the quarter ended June 30, beating analysts’ expectations. Cipla shares spiked immediately after the earnings announcement as the results were announced during the market hours, finishing the day 3.0 per…
